Skip to main content

Kapvay FDA Approval History

FDA Approved: Yes (First approved September 28, 2010)
Brand name: Kapvay
Generic name: clonidine hydrochloride
Dosage form: Extended-Release Tablets
Company: Shionogi Inc.
Treatment for: ADHD

Kapvay (clonidine hydrochloride) is a centrally acting alpha2-adrenergic agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications.

Development timeline for Kapvay

Oct  4, 2010Approval Shionogi Announces FDA Approval of Kapvay - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.